Circadian Rhythms, Cancers and Chronotherapy
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 5585
Special Issue Editors
2. Cancer Chronotherapy Team, Cancer Research Centre, Division of Biomedical Sciences, Warwick Medical School, Coventry CV4 7AL, UK
3. Centre Hépato Biliaire, AP-HP, Hôpital Paul Brousse (APHP), 94800 Villejuif, France
Interests: circadian clocks; biological rhythms; chronopharmacology; chronotherapy; gastro-intestinal oncology; biomakers; digital health
2. Cancer Research Centre, Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK
3. UPR “Chronotherapy, Cancers and Transplantation”, Faculty of Medicine, Paris-Saclay University, 94800 Villejuif, France
Interests: cancer chronotherapeutics; circadian rhythms; supportive care; digital health
Special Issue Information
Dear Colleagues,
This Special Issue on “Circadian rhythms, Cancers and Chronotherapy” aims at advancing precision and personalized cancer medicine. Toward such goal, we are pleased to invite you to submit original or review scientific or biomedical articles on these topics. We welcome original contributions reporting new challenging scientific results and/or highlighting novel approaches regarding the molecular, cellular, and physiologic interactions between circadian rhythms and cancer processes and treatments, as well as their healthcare implications. Indeed, a hierarchical network of cellular clocks, consisting of a system of 15 clock genes, orchestrates cellular metabolism, proliferation, and survival, as well as physiology and responses to therapeutic agents, over a 24 h timescale. Accumulating evidence supports an important role of circadian rhythms both for carcinogenesis processes from initiation to progression and metastasis, and for the tolerability and efficacy of all kinds of cancer treatments. However, circadian rhythms can differ as a function of sex, age, environment, genetics, or other biological factors in experimental cancer models, among people at risk of cancer, and among cancer patients. Manuscripts on the relevance of circadian or other biological clocks in the following research areas may include (but are not limited to):
- In vitro and in vivo experimental cancer models
- Drug development and chronotherapy
- Chemotherapy, immunotherapy, targeted agents, radiotherapy, surgery
- Circadian host or tumor biomarkers
- Electronic patient-reported outcomes
- Circadian rhythms and sleep
- Sex- and age specificities
- Clinical trial designs
- Mathematical models and artificial intelligence
- Digital healthcare, telemedicine, logistics
We look forward to receiving your contributions.
Prof. Dr. Francis Levi
Dr. Pasquale F. Innominato
Dr. Esra Tasali
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- circadian rhythms
- clock genes
- carcinogenesis
- chronotherapy, biomarkers
- patient-reported outcomes
- sleep
- sex
- precision oncology
- artificial intelligence
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.